echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Science: Experts outline SARS-CoV-2 vaccine development plan

    Science: Experts outline SARS-CoV-2 vaccine development plan

    • Last Update: 2020-05-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    2020 May 14 News /BioValleyBIOON / - Recently, Science magazine published an opinion piece, the authors propose will require unprecedented cooperation and resource to research and development of safe and effective COVID-19 vaccine to the scale of production and the number of one billion people around the globe to delivervaccine development usually takes several yearsIn order to speed up the process, Fred Hutchinson Cancer Research Center (FredHutchinsonCancerResearchCenter) DrLarryCorey and the US National Institutes of Health experts have put forward a vision, namely to create a coordinated and effective way to produce COVID-19 vaccineSource: ScienceIn this perspective article, Corey and co-author Drthose AnthonyFauci, DrJohnMascola and DrFrancisCollins will share their industry, government and academia together to meet this urgent need the plan ofDrFauci is director of the US National Institute of Allergy Infectious Diseases under the National Institutes of Health (NIH)DrMascola, director of NIAID's Vaccine Research Center, DrCollins is the director of the NIH "We are going through a series of unprecedented events, the disease has spread across the globe, the number of infections within a short time to be more than any other infection than modern," FredHutch the former president and director, vaccines and professor of infectious diseases department Corey said "In order to overcome the challenges before us, each of us needs to do our best Novel coronavirus vaccine research and development needs creativity, cooperation and commitment to save as many lives as soon as possible." in the development of vaccines, therapy and immunotherapy entire career, Corey under public funding of NIH successfully integrated academic institutions, biotechnology and pharmaceutical companies He said: "In addition to the scientists and health experts, we also need to help the industry across the country and affected communities to participate in large-scale trials of possible new coronavirus vaccines." Author every step calls for the coordination process, from the creation of a common set of criteria to evaluate the oversight bodies and the ongoing vaccine research, enhance transparency and data sharing, centralized private, eventually expanding COVID-19 vaccine production capacity and distribution of all resources in the public and philanthropic sectors chain Corey said: "We want to see a variety of successful vaccines and vaccine platform can meet the world's billions of adults and children vaccinated and the recovery of world economy and health needs." (Bio Valley Bioon.com) a reference: ExpertsoutlineplanforCOVID-19vaccines LawrenceCoreyetal AstrategicapproachtoCOVID-19vaccineR & D .Science.2020.DOI: 10.1126 / science.abc5312
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.